Home
>
US Stocks
>
Axonics Inc
Axonics Inc
AXNX

Axonics Inc (AXNX)

$67.36.99%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
66.95
Today Low/High
66.95 / 68
52 Week Low/High
$34 / $72.48
Market Cap
$3.19B

Company Details

Based in Irvine, Calif., Axonics has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for patients with bladder and bowel dysfunction, and through its acquisition of Bulkamid®, offers a best-in-class urethral bulking agent for women with stress urinary incontinence. These conditions significantly impact quality of life. Overactive bladder affects an estimated 87 million adults in the U.S. and Europe, with an additional 40 million adults estimated to suffer from fecal incontinence. Stress urinary incontinence affects an estimated 20 million women in the U.S. alone. Axonics' clinically proven products are offered at hundreds of medical centers across the U.S. and abroad. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries.
Organisation
Axonics Inc
Headquaters
Irvine, California, US
Employees
416
Industry
Health Technology
CEO
Raymond Cohen

Discover more

Frequently Asked Questions

What is Axonics Inc (AXNX) share price today?

Can Indians buy Axonics Inc (AXNX) shares?

How can I buy Axonics Inc (AXNX) shares from India?

Can Fractional shares of Axonics Inc (AXNX) be purchased?

What are the documents required to start investing in Axonics Inc (AXNX) stocks?

We are a SEBI registered investement advisor